F. Arcuri, S. Papa, and A. Carducci, Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: Expression, distribution, and calcium binding activity, The Prostate, vol.2, issue.3, pp.130-140, 2004.
DOI : 10.1002/pros.20054

U. Bommer and B. Thiele, The translationally controlled tumour protein (TCTP), The International Journal of Biochemistry & Cell Biology, vol.36, issue.3, pp.379-385, 2004.
DOI : 10.1016/S1357-2725(03)00213-9

S. Chen, P. Wu, and C. Chou, A Knockout Mouse Approach Reveals that TCTP Functions as an Essential Factor for Cell Proliferation and Survival in a Tissue- or Cell Type-specific Manner, Molecular Biology of the Cell, vol.18, issue.7, pp.2525-2532, 2007.
DOI : 10.1091/mbc.E07-02-0188

J. Jung, H. Kim, M. Kim, K. Sohn, M. Kim et al., Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src, Oncogene, vol.20, issue.19, pp.2264-2274, 2011.
DOI : 10.1038/onc.2010.604

M. Lucibello, A. Gambacurta, and M. Zonfrillo, TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death, Experimental Cell Research, vol.317, issue.17, pp.2479-2489, 2011.
DOI : 10.1016/j.yexcr.2011.07.012

A. Telerman and R. Amson, The molecular programme of tumour reversion: the steps beyond malignant transformation, Nature Reviews Cancer, vol.101, issue.3, pp.206-216, 2009.
DOI : 10.1038/nrc2589

F. Li, D. Zhang, and K. Fujise, Characterization of Fortilin, a Novel Antiapoptotic Protein, Journal of Biological Chemistry, vol.276, issue.50, pp.47542-47549, 2001.
DOI : 10.1074/jbc.M108954200

M. Tuynder, L. Susini, and S. Prieur, Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1, Proceedings of the National Academy of Sciences, vol.276, issue.50, pp.14976-14981, 2002.
DOI : 10.1074/jbc.M108954200

M. Tuynder, G. Fiucci, and S. Prieur, Translationally controlled tumor protein is a target of tumor reversion, Proceedings of the National Academy of Sciences, vol.16, issue.16, pp.15364-15369, 2004.
DOI : 10.1038/sj.onc.1201729

L. Bai and W. Zhu, p53: structure, function and therapeutic applications, J Cancer Molecules, vol.2, pp.141-153, 2006.

S. Jafarnejad and G. Li, Regulation of p53 by ING family members in suppression of tumor initiation and progression, Cancer and Metastasis Reviews, vol.291, issue.5, pp.55-73, 2012.
DOI : 10.1007/s10555-011-9329-5

L. Larsson, Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence, Seminars in Cancer Biology, vol.21, issue.6, pp.367-376, 2011.
DOI : 10.1016/j.semcancer.2011.10.005

A. Puzio-kuter, The Role of p53 in Metabolic Regulation, Genes & Cancer, vol.2, issue.4, pp.385-391, 2011.
DOI : 10.1177/1947601911409738

J. Zhao, Y. Lu, and H. Shen, Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells, Cancer Letters, vol.314, issue.1, pp.8-23, 2012.
DOI : 10.1016/j.canlet.2011.09.040

R. Amson, S. Pece, and A. Lespagnol, Reciprocal repression between P53 and TCTP, Nature Medicine, vol.9, issue.1, pp.91-99, 2011.
DOI : 10.1073/pnas.0400177101

S. Rho, J. Lee, and M. Park, Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53, FEBS Letters, vol.95, issue.1, pp.29-35, 2011.
DOI : 10.1016/j.febslet.2010.11.014

F. Bazile, A. Pascal, I. Arnal, L. Clainche, C. Chesnel et al., Complex relationship between TCTP, microtubules and actin microfilaments regulates cell shape in normal and cancer cells, Carcinogenesis, vol.30, issue.4, pp.555-565, 2009.
DOI : 10.1093/carcin/bgp022
URL : https://hal.archives-ouvertes.fr/inserm-00365989

K. Tsarova, E. Yarmola, and M. Bubb, Identification of a cofilin-like actin-binding site on translationally controlled tumor protein (TCTP), FEBS Letters, vol.346, issue.23, pp.4756-4760, 2010.
DOI : 10.1016/j.febslet.2010.10.054

C. Ballestrem, B. Wehrle-haller, B. Hinz, and B. Imhof, Actin-dependent Lamellipodia Formation and Microtubule-dependent Tail Retraction Control-directed Cell Migration, Molecular Biology of the Cell, vol.11, issue.9, pp.2999-3012, 2000.
DOI : 10.1091/mbc.11.9.2999
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC14971

M. Beil, A. Micoulet, and G. Von-wichert, Sphingosylphosphorylcholine regulates keratin network architecture and visco-elastic properties of human cancer cells, Nature Cell Biology, vol.5, issue.9, pp.803-811, 2003.
DOI : 10.1038/ncb1037

A. Creekmore, W. Silkworth, D. Cimini, R. Jensen, P. Roberts et al., Changes in Gene Expression and Cellular Architecture in an Ovarian Cancer Progression Model, PLoS ONE, vol.25, issue.3, p.17676, 2011.
DOI : 10.1371/journal.pone.0017676.s002

B. Czernobilsky, Intermediate Filaments in Ovarian Tumors, International Journal of Gynecological Pathology, vol.12, issue.2, pp.166-169, 1993.
DOI : 10.1097/00004347-199304000-00014

C. Ip, A. Cheung, H. Ngan, and A. Wong, p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells, Oncogene, vol.127, issue.21, pp.2420-2432, 2011.
DOI : 10.1210/en.2005-1404

A. Ketene, E. Schmelz, P. Roberts, and M. Agah, The effects of cancer progression on the viscoelasticity of ovarian cell cytoskeleton structures, Nanomedicine: Nanotechnology, Biology and Medicine, vol.8, issue.1, pp.93-102, 2012.
DOI : 10.1016/j.nano.2011.05.012

M. Korabiowska, I. Ruschenburg, and H. Schulz, Cytokeratin expression correlates with aneuploidy in cytological specimens of melanoma metastases, Anticancer Res, vol.25, pp.2789-2792, 2005.

R. Moll, Cytokeratins in the histological diagnosis of malignant tumors, Int J Biol Markers, vol.9, pp.63-69, 1994.

N. Said, I. Najwer, M. Socha, D. Fulton, S. Mok et al., SPARC Inhibits LPA-Mediated Mesothelial???Ovarian Cancer Cell Crosstalk, Neoplasia, vol.9, issue.1, pp.23-35, 2007.
DOI : 10.1593/neo.06658
URL : http://doi.org/10.1593/neo.06658

J. Shankar, A. Messenberg, J. Chan, T. Underhill, L. Foster et al., Pseudopodial Actin Dynamics Control Epithelial-Mesenchymal Transition in Metastatic Cancer Cells, Cancer Research, vol.70, issue.9, pp.3780-3790, 2010.
DOI : 10.1158/0008-5472.CAN-09-4439

S. Sharma, C. Santiskulvong, L. Bentolila, J. Rao, O. Dorigo et al., Correlative nanomechanical profiling with super-resolution F-actin imaging reveals novel insights into mechanisms of cisplatin resistance in ovarian cancer cells, Nanomedicine: Nanotechnology, Biology and Medicine, vol.8, issue.5, pp.757-766, 2012.
DOI : 10.1016/j.nano.2011.09.015

B. Tanos and E. Rodriguez-boulan, The epithelial polarity program: machineries involved and their hijacking by cancer, Oncogene, vol.10, issue.55, pp.6939-6957, 2008.
DOI : 10.1083/jcb.200502055

D. Vergara, B. Merlot, and J. Lucot, Epithelial???mesenchymal transition in ovarian cancer, Cancer Letters, vol.291, issue.1, pp.59-66, 2010.
DOI : 10.1016/j.canlet.2009.09.017

M. Yilmaz and G. Christofori, EMT, the cytoskeleton, and cancer cell invasion, Cancer and Metastasis Reviews, vol.20, issue.1, pp.15-33, 2009.
DOI : 10.1007/s10555-008-9169-0

Y. Zhang, M. Zhang, and H. Dong, Deacetylation of cortactin by SIRT1 promotes cell migration, Oncogene, vol.27, issue.3, pp.445-460, 2009.
DOI : 10.1038/onc.2008.388

A. Jemal, R. Siegel, J. Xu, and E. Ward, Cancer Statistics, 2010, CA: A Cancer Journal for Clinicians, vol.60, issue.5, pp.277-300, 2010.
DOI : 10.3322/caac.20073

P. Secchiero, E. Rimondi, G. Di-iasio, M. Voltan, R. Gonelli et al., Activation of the p53 pathway induces ??-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages, Journal of Cellular Physiology, vol.73, issue.5, pp.1829-1837, 2012.
DOI : 10.1002/jcp.22910

N. Arsic, N. Bendris, and M. Peter, A novel function for Cyclin A2: Control of cell invasion via RhoA signaling, The Journal of Cell Biology, vol.113, issue.1, pp.147-162, 2012.
DOI : 10.1074/jbc.M406082200
URL : https://hal.archives-ouvertes.fr/hal-00714616

D. Millimaggi, M. Mari, D. Ascenzo, and S. , Tumor Vesicle???Associated CD147 Modulates the Angiogenic Capability of Endothelial Cells, Neoplasia, vol.9, issue.4, pp.349-357, 2007.
DOI : 10.1593/neo.07133

H. Kenny, S. Kaur, L. Coussens, and E. Lengyel, The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin, Journal of Clinical Investigation, vol.118, issue.4, pp.1367-1379, 2008.
DOI : 10.1172/JCI33775

S. Bilinski, M. Jaglarz, M. Dougherty, and M. Kloc, Electron microscopy, immunostaining, cytoskeleton visualization, in situ hybridization, and three-dimensional reconstruction of Xenopus oocytes, Methods, vol.51, issue.1, pp.11-19, 2010.
DOI : 10.1016/j.ymeth.2009.12.003

B. Willipinski-stapelfeldt, S. Riethdorf, and V. Assmann, Changes in Cytoskeletal Protein Composition Indicative of an Epithelial-Mesenchymal Transition in Human Micrometastatic and Primary Breast Carcinoma Cells, Clinical Cancer Research, vol.11, issue.22, pp.8006-8014, 2005.
DOI : 10.1158/1078-0432.CCR-05-0632

M. Yilmaz and G. Christofori, Mechanisms of Motility in Metastasizing Cells, Molecular Cancer Research, vol.8, issue.5, pp.629-642, 2010.
DOI : 10.1158/1541-7786.MCR-10-0139

J. Gagne, C. Ethier, and P. Gagne, Comparative proteome analysis of human epithelial ovarian cancer, Proteome Science, vol.5, issue.1, p.16, 2007.
DOI : 10.1186/1477-5956-5-16

A. Nagaraja, C. Creighton, and Z. Yu, A Link between mir-100 and FRAP1/mTOR in Clear Cell Ovarian Cancer, Molecular Endocrinology, vol.24, issue.2, pp.447-463, 2010.
DOI : 10.1210/me.2009-0295

F. Brioudes, A. Thierry, P. Chambrier, B. Mollereau, and M. Bendahmane, Translationally controlled tumor protein is a conserved mitotic growth integrator in animals and plants, Proceedings of the National Academy of Sciences, vol.28, issue.2, pp.16384-16389, 2010.
DOI : 10.1002/1526-968X(200010)28:2<82::AID-GENE60>3.0.CO;2-Z
URL : https://hal.archives-ouvertes.fr/hal-00521824

H. Kaufmann, R. Marone, M. A. Olayioye, E. Baileyj, and M. Fussenegger, Characterization of an N-terminally Truncated Cyclin A Isoform in Mammalian Cells, Journal of Biological Chemistry, vol.276, issue.32, pp.29987-29993, 2001.
DOI : 10.1074/jbc.M005452200

R. Van-dross, P. J. Browning, and J. Pelling, Do truncated cyclins contribute to aberrant cyclin expression in cancer? Cell Cycle, pp.472-477, 2006.

I. Kalaszczynska, Y. Geng, and T. Iino, Cyclin A Is Redundant in Fibroblasts but Essential in Hematopoietic and Embryonic Stem Cells, Cell, vol.138, issue.2, pp.352-365, 2009.
DOI : 10.1016/j.cell.2009.04.062

N. Winston, F. Bourgain-guglielmetti, and A. Ciemerych, Early Development of Mouse Embryos Null Mutant for the Cyclin A2 Gene Occurs in the Absence of Maternally Derived Cyclin A2 Gene Products, Developmental Biology, vol.223, issue.1, pp.139-153, 2000.
DOI : 10.1006/dbio.2000.9721